Bath & Body Works, Inc. (NYSE:BBWI) Position Boosted by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. raised its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 30.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 137,610 shares of the company's stock after purchasing an additional 32,233 shares during the period. Nomura Asset Management Co. Ltd. owned about 0.06% of Bath & Body Works worth $4,393,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Anomaly Capital Management LP purchased a new stake in Bath & Body Works in the 2nd quarter valued at approximately $113,995,000. FMR LLC raised its holdings in shares of Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock worth $80,315,000 after acquiring an additional 2,501,828 shares during the last quarter. KBC Group NV lifted its position in shares of Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after acquiring an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH acquired a new stake in shares of Bath & Body Works during the third quarter valued at $50,483,000. Finally, Lone Pine Capital LLC boosted its stake in shares of Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company's stock valued at $441,871,000 after acquiring an additional 1,547,399 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Insider Activity at Bath & Body Works

In other news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The stock was acquired at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.27% of the company's stock.

Bath & Body Works Price Performance

BBWI stock traded up $0.82 during midday trading on Friday, reaching $38.22. 3,182,032 shares of the company's stock traded hands, compared to its average volume of 4,017,254. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99. The business has a 50-day moving average price of $32.59 and a two-hundred day moving average price of $34.68. The company has a market capitalization of $8.28 billion, a P/E ratio of 9.32, a PEG ratio of 1.44 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, beating analysts' consensus estimates of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the firm posted $0.48 EPS. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, research analysts forecast that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.09%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works's payout ratio is 19.51%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on BBWI. BMO Capital Markets reissued an "outperform" rating and issued a $50.00 target price (down previously from $52.00) on shares of Bath & Body Works in a research note on Thursday, August 29th. Evercore ISI reduced their price objective on shares of Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating on the stock in a research note on Wednesday, August 28th. UBS Group lowered their target price on shares of Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating for the company in a research note on Thursday, August 29th. Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating for the company in a report on Tuesday, August 20th. Finally, Raymond James decreased their price objective on Bath & Body Works from $51.00 to $42.00 and set an "outperform" rating on the stock in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $42.50.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.